Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PUMA BIOTECHNOLOGY, INC. Director's Dealing 2016

May 27, 2016

33488_dirs_2016-05-27_b7ba5339-a945-4a18-822d-df2ad2640499.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2016-05-25

Reporting Person: EYLER CHARLES R (SEE REMARKS)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-25 Stock Option (Right to Buy) $35.61 A 30000 Acquired 2026-05-24 Common Stock (30000) Direct

Footnotes

F1: The vesting commencement date ("Vesting Commencement Date") of the option is May 25, 2016. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to Reporting Person's continued services with the Issuer.